remeron
merck sharp & dohme australia pty ltd - mirtazapine -
agmerch bifenthrin 100 ec insecticide
agmerch pty ltd - bifenthrin; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; n-methyl-2-pyrrolidone solvent other 50.0 g/l; liquid hydrocarbon solvent other 605.0 g/l - insecticide
agmerch triasulfuron 750 wg herbicide
agmerch pty ltd - triasulfuron - water dispersible granule - triasulfuron urea-sulfonyl active 750.0 g/kg - herbicide
agmerch metsulfuron 600 wg herbicide
agmerch pty ltd - metsulfuron-methyl - water dispersible granule - metsulfuron-methyl urea-sulfonyl active 600.0 g /kg - herbicide
agmerch imidacloprid 200 sc insecticide
agmerch pty ltd - imidacloprid - suspension concentrate - imidacloprid guanidine active 200.0 g/l - insecticide
agmerch gibberellic acid 200 wg growth regulator
agmerch pty ltd - gibberellic acid - water dispersible granule - gibberellic acid plant growth regulator active 200.0 g /kg - growth regulator
agmerch mancozeb 750 wg fungicide
agmerch pty ltd - mancozeb - water dispersible granule - mancozeb carbamate-dithiocarbamate active 750.0 g/kg - fungicide
agmerch fluroxypyr ssd 400 herbicide
agmerch pty ltd - fluroxypyr as the methyl heptyl ester; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 400.0 g/l; n-methyl-2-pyrrolidone solvent other 46.0 g/l; liquid hydrocarbon solvent other 314.0 g/l - herbicide
mercilon 21
merck sharp & dohme (new zealand) limited - desogestrel 150ug; ; ethinylestradiol 20ug; - tablet - active: desogestrel 150ug ethinylestradiol 20ug excipient: colloidal silicon dioxide dl-alpha tocopherol lactose monohydrate magnesium stearate potato starch povidone stearic acid
zostavax- zoster vaccine live injection, powder, lyophilized, for suspension sterile diluent- sterile water injection
merck sharp & dohme llc - varicella-zoster virus strain oka/merck live antigen (unii: gpv39zgd8c) (varicella-zoster virus strain oka/merck live antigen - unii:gpv39zgd8c) - varicella-zoster virus strain oka/merck live antigen 19400 [pfu] in 0.65 ml - zostavax® is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older. limitations of use of zostavax: - zostavax is not indicated for the treatment of zoster or postherpetic neuralgia (phn). - zostavax is not indicated for prevention of primary varicella infection (chickenpox). do not administer zostavax to individuals with a history of anaphylactic/anaphylactoid reaction to gelatin, neomycin or any other component of the vaccine. neomycin allergy manifested as contact dermatitis is not a contraindication to receiving this vaccine. {1} do not administer zostavax to individuals who are immunodeficient or immunosuppressed due to disease or therapy, as serious or fatal disseminated vaccine strain varicella-zoster virus disease may occur. causes of immunodeficiency or immunosuppression may include, but are not limited to, primary or acquired immunodeficiency states, aids or other clinical manifestations of infection with human immunodeficiency